Memantine Arrow Lab

Memantine, the active ingredient in Memantine Arrow Lab, is an NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to improve cognition and daily functioning by reducing excitotoxic neuronal damage.

GNH USA supplies Memantine Arrow Lab as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to European Union quality standards. The company serves hospitals, pharmacies and clinics worldwide, providing reliable sourcing for clinicians managing neurodegenerative conditions.

Memantine is employed in the therapeutic armamentarium for Alzheimer’s disease, a progressive neurodegenerative condition characterized by memory loss, impaired reasoning, and functional decline. Clinical use focuses on patients with moderate to severe disease where it can provide symptomatic benefit. - Alzheimer’s disease: improves cognitive function and daily living activities in patients with moderate to severe disease. - Mild‑to‑moderate Alzheimer’s disease (as adjunct to cholinesterase inhibitors): may provide additional cognitive benefit when combined with standard therapy.

Memantine may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (rash, swelling, anaphylaxis) - Hallucinations or psychotic symptoms - Suicidal thoughts or behavior

When prescribing memantine, clinicians should consider several safety aspects. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic impairment: monitor liver function tests during therapy. - Psychiatric disorders: use caution in patients with a history of psychosis. - Concomitant use with other NMDA antagonists: avoid combined therapy due to additive CNS effects. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Memantine can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Amantadine: combined use may increase risk of neuropsychiatric effects. - Other NMDA antagonists: additive central nervous system depression. - Strong CYP450 inducers (e.g., carbamazepine): may lower memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish therapeutic benefit of memantine. - Diuretics: can raise memantine plasma levels, requiring monitoring. - Alcohol: may enhance dizziness and other CNS effects.